|
|
|
Volumn 143, Issue 2, 2002, Pages 229-234
|
|
Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTITHROMBIN;
DRUG DERIVATIVE;
HEPARIN;
HIRUDIN DERIVATIVE;
HIRULOG;
PEPTIDE FRAGMENT;
RECOMBINANT PROTEIN;
AGED;
ANTICOAGULANT THERAPY;
ARTICLE;
BLEEDING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
HEART INFARCTION;
HUMAN;
MALE;
MORTALITY;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
RISK;
UNSTABLE ANGINA PECTORIS;
AGED;
ANGINA, UNSTABLE;
ANTICOAGULANTS;
ANTITHROMBINS;
DOUBLE-BLIND METHOD;
FEMALE;
HEMORRHAGE;
HEPARIN;
HIRUDIN THERAPY;
HIRUDINS;
HUMANS;
MALE;
MYOCARDIAL INFARCTION;
ODDS RATIO;
PEPTIDE FRAGMENTS;
RECOMBINANT PROTEINS;
RECURRENCE;
|
|
EID: 0036482419
PISSN: None
EISSN: 10976744
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (65)
|
|
References (0)
|
